In addition, RAD-treated patients showed a trend towards a lower incidence of HCMV infection.
← all excerpts
Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.
1
—
—